虾青素补充对心力衰竭受试者炎症标志物、氧化应激指标、血脂谱、尿酸水平、血压、内皮功能、生活质量及疾病症状的影响
本研究为为期8周的双盲随机对照临床试验,计划将心力衰竭受试者随机分为干预组(每日服用含20 mg虾青素的胶囊,n=40)和安慰剂组(每日服用含20 mg麦芽糊精的胶囊,n=40)。研究将在干预前后测量尿酸、血脂谱、氧化应激指标、炎症标志物、血压、一氧化氮及人体测量指标,并填写生活质量、疲劳强度、呼吸短促和食欲问卷,以评估虾青素补充对上述指标的影响。
要点
- 为期8周的双盲随机对照临床试验,干预组每日20 mg虾青素,安慰剂组每日20 mg麦芽糊精,每组n=40。
- 结局包括炎症标志物、氧化应激指标、血脂谱、尿酸、血压、内皮功能、生活质量及疾病症状。
- 试验注册号IRCT20200429047235N3,注册日期2024年3月26日。
核心结论
- 本试验旨在评估虾青素补充对心力衰竭受试者炎症状态、氧化应激、血脂谱、尿酸水平、内皮功能、生活质量和疾病症状的影响。
研究设计与样本
- 双盲随机对照临床试验,为期8周,心力衰竭受试者随机分为干预组(每日含20 mg虾青素的胶囊,n=40)和安慰剂组(每日含20 mg麦芽糊精的胶囊,n=40)。
- 干预前后测量尿酸、血脂谱、氧化应激指标、炎症标志物、血压、一氧化氮及人体测量指标,并填写生活质量、疲劳强度、呼吸短促和食欲问卷。
- 使用SPSS version 22软件进行统计分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure is a chronic and progressive disease where the heart muscle is unable to pump enough blood and oxygen to meet the body's needs. Oxidative stress and inflammation are key elements in the development and progression of heart failure. Astaxanthin, a carotenoid, has strong anti-inflammatory and antioxidant effects that may protect the cardiovascular system. A study will evaluate the effect of astaxanthin supplementation on inflammatory status, oxidative stress, lipid profile, uric acid levels, endothelial function, quality of life, and disease symptoms in people with heart failure. METHODS: The current study is a double-blind controlled randomized clinical trial for 8 weeks, in which people with heart failure were randomly assigned to two groups: intervention (one capsule containing 20 mg of astaxanthin per day, n = 40) and placebo (one capsule containing 20 mg of maltodextrin per day, n = 40) will be divided. At the beginning and end of the intervention, uric acid, lipid profile, oxidative stress indices, inflammatory markers, blood pressure, nitric oxide, and anthropometric factors will be measured, and questionnaires measuring quality of life, fatigue intensity, shortness of breath, and appetite will be completed. SPSS version 22 software will be used for statistical analysis. DISCUSSION: There is a growing global interest in natural and functional food products. This RCT contributes to the expanding body of research on the potential benefits of astaxanthin in heart failure patients, including its antioxidant, lipid-lowering, and anti-inflammatory effects. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT20200429047235N3. Registered on 26 March 2024.
引用
- Mohammadi SG, Feizi A, Bagherniya M, et al. The effect of astaxanthin supplementation on inflammatory markers, oxidative stress indices, lipid profile, uric acid level, blood pressure, endothelial function, quality of life, and disease symptoms in heart failure subjects. Trials. 2024. PMID: 39090754. doi:10.1186/s13063-024-08339-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。